You are here
Verax Corp
UEI: N/A
# of Employees: N/A
HUBZone Owned: No
Socially and Economically Disadvantaged: No
Woman Owned: No
Award Charts
Award Listing
-
PRODUCTION OF HIV GP-120 PROTEIN
Amount: $50,000.00THE TERMINAL NATURE OF HIV INFECTIONS HAS PROMPTED DEMANDS FOR LARGE QUANTITIES OF HIV PROTEINS FOR RESEARCH RELATED TO UNDERSTANDING THE VIRUS AND DEVELOPING THERAPEUTIC TREATMENTS. VERAX CORPORATION ...
SBIRPhase I1989Department of Health and Human Services -
DEFINED MEDIA FOR CONTINUOUS CULTURE OF MAMMALIAN CELLS
Amount: $48,000.00WITH THE ADVENT OF GENETIC ENGINEERING TECHNOLOGY, IT HAS BECOME CLEAR THAT THERE IS A GROWING NEED TO PRODUCE CLONED CELL PRODUCTS IN LARGER QUANTITIES FOR THE TREATMENT OF VARIOUS CARDIOVASCULAR, IM ...
SBIRPhase I1988Department of Health and Human Services -
MATHEMATICAL MODELING OF MAMMALIAN CELLS
Amount: $206,000.00THE RECENT DEVELOPMENT OF MOLECULAR BIOLOGY, PARTICULARLY INTHE FIELD OF RECOMBINANT DNA TECHNOLOGY, GIVES BIRTH TO A NEW ERA IN MEDICAL THERAPEUTICS AND DIAGNOSTICS USING PRODUCTS FROM MAMMALIAN CELL ...
SBIRPhase II1987National Science Foundation -
A NOVEL SYSTEM FOR HUMAN HYBRIDOMA CULTURE
Amount: $43,000.00WITH THE ADVENT OF MONOCLONAL ANTIBODY TECHNOLOGY, IT HAS BECOME CLEAR THAT THERE IS A GROWING NEED TO PRODUCE HUMAN CELLS AND CELL PRODUCTS IN LARGER QUANTITIES FOR THE TREATMENT OF VARIOUS IMMUNOLOG ...
SBIRPhase I1987Department of Health and Human Services -
THE CULTURE ENVIRONMENT IN WHICH A MAMMALIAN CELL IS MAINTAINED CAN PROFOUNDLY INFLUENCE ITS STATE OF DIFFERENTIATION AND ITS LONGEVITY AS WELL AS ITS GROWTH RATEAND PRODUCTIVITY.
Amount: $50,000.00THE CULTURE ENVIRONMENT IN WHICH A MAMMALIAN CELL IS MAINTAINED CAN PROFOUNDLY INFLUENCE ITS STATE OF DIFFERENTIATION AND ITS LONGEVITY AS WELL AS ITS GROWTH RATEAND PRODUCTIVITY. VERAX CORPORATION HA ...
SBIRPhase I1986Department of Health and Human Services -
WITH THE ADVENT OF MONOCLONAL ANTIBODY TECHNOLOGY, TWO THINGS HAVE BECOME INCREASINGLY OBVIOUS: 1.
Amount: $47,000.00WITH THE ADVENT OF MONOCLONAL ANTIBODY TECHNOLOGY, TWO THINGS HAVE BECOME INCREASINGLY OBVIOUS: 1. THESE MOLECULESWILL BE NEEDED IN KILOGRAM QUANTITIES FOR THE TREATMENT OF AVARIETY OF MALIGNANCIES. 2 ...
SBIRPhase I1986Department of Health and Human Services -
THE USE OF IN VITRO PRODUCED MONOCLONAL ANTIBODIES FOR THE TREATMENT OF IMMUNOLOGIC, INFECTIOUS, AND NEOPLASTIC DISEASES IN HUMANS IS PROJECTED TO INCREASE SHARPLY IN THE UPCOMING YEARS.
Amount: $50,000.00THE USE OF IN VITRO PRODUCED MONOCLONAL ANTIBODIES FOR THE TREATMENT OF IMMUNOLOGIC, INFECTIOUS, AND NEOPLASTIC DISEASES IN HUMANS IS PROJECTED TO INCREASE SHARPLY IN THE UPCOMING YEARS. VERAX CORPORA ...
SBIRPhase I1986Department of Health and Human Services -
THE OBJECTIVE OF THIS PROJECT IS TO DEMONSTRATE THE FEASIBILITY OF EFFICIENTLY PRODUCING BIOCHEMICALS FROM MAMMALIAN FIBROBLASTS BY A NOVEL METHOD OF CONTINUOUS CULTURE WITH IMMOBILIZED CELLS.
Amount: $38,378.00THE OBJECTIVE OF THIS PROJECT IS TO DEMONSTRATE THE FEASIBILITY OF EFFICIENTLY PRODUCING BIOCHEMICALS FROM MAMMALIAN FIBROBLASTS BY A NOVEL METHOD OF CONTINUOUS CULTURE WITH IMMOBILIZED CELLS. THE NOV ...
SBIRPhase I1985Department of Health and Human Services -
THE OBJECTIVE OF THIS PHASE I PROJECT IS TO DEMONSTRATE THE FEASIBILITY OF A NOVEL APPROACH TO CULTURING CELLS IN ORDER TO PRECISELY DETERMINE THEIR RESPONSE TO ENVIRONMENTAL CHANGES.
Amount: $46,976.00THE OBJECTIVE OF THIS PHASE I PROJECT IS TO DEMONSTRATE THE FEASIBILITY OF A NOVEL APPROACH TO CULTURING CELLS IN ORDER TO PRECISELY DETERMINE THEIR RESPONSE TO ENVIRONMENTAL CHANGES. THIS APPROACH WI ...
SBIRPhase I1985Department of Health and Human Services -
MATHEMATICAL MODELING OF MAMMALIAN CELLS
Amount: $39,000.00N/A
SBIRPhase I1985National Science Foundation
